290 related articles for article (PubMed ID: 27209163)
1. Iranian consensus on use of vitamin D in patients with multiple sclerosis.
Jahromi SR; Sahraian MA; Togha M; Sedighi B; Shayegannejad V; Nickseresht A; Nafissi S; Mohebbi N; Majdinasab N; Foroughipour M; Etemadifar M; Moghadam NB; Ayramlou H; Ashtari F; Alaie S
BMC Neurol; 2016 May; 16():76. PubMed ID: 27209163
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
3. Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.
Miele G; Abbadessa G; Cavalla P; Valentino P; Marfia GA; Landi D; Bosa C; Vercellino M; De Martino A; Ponzano M; Lavorgna L; Bonavita S
Mult Scler Relat Disord; 2022 Dec; 68():104395. PubMed ID: 36544324
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease.
Klapdor S; Richter E; Klapdor R
Anticancer Res; 2012 May; 32(5):1991-8. PubMed ID: 22593477
[TBL] [Abstract][Full Text] [Related]
5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and multiple sclerosis: review of a possible association.
Summerday NM; Brown SJ; Allington DR; Rivey MP
J Pharm Pract; 2012 Feb; 25(1):75-84. PubMed ID: 21987526
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and multiple sclerosis: An update.
Pierrot-Deseilligny C; Souberbielle JC
Mult Scler Relat Disord; 2017 May; 14():35-45. PubMed ID: 28619429
[TBL] [Abstract][Full Text] [Related]
8. [The role of vitamin D in the pathogenesis and course of multiple sclerosis].
Góral A; Brola W; Kasprzyk M; Przybylski W
Wiad Lek; 2015; 68(1):60-6. PubMed ID: 26094335
[TBL] [Abstract][Full Text] [Related]
9. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
[TBL] [Abstract][Full Text] [Related]
10. The Role of Vitamin D in Multiple Sclerosis: Biology and Biochemistry, Epidemiology and Potential Roles in Treatment.
Simpson S; der Mei IV; Taylor B
Med Chem; 2018 Feb; 14(2):129-143. PubMed ID: 28933265
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D in multiple sclerosis: implications for assessment and treatment.
Holmøy T; Kampman MT; Smolders J
Expert Rev Neurother; 2012 Sep; 12(9):1101-12. PubMed ID: 23039389
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore.
Holmøy T; Torkildsen Ø; Myhr KM; Løken-Amsrud KI
Acta Neurol Scand Suppl; 2012; (195):63-9. PubMed ID: 23278659
[TBL] [Abstract][Full Text] [Related]
13. [Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)].
Adami S; Romagnoli E; Carnevale V; Scillitani A; Giusti A; Rossini M; Gatti D; Nuti R; Minisola S;
Reumatismo; 2011 Nov; 63(3):129-47. PubMed ID: 22257914
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A
Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049
[TBL] [Abstract][Full Text] [Related]
15. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial.
Gallagher JC; Sai A; Templin T; Smith L
Ann Intern Med; 2012 Mar; 156(6):425-37. PubMed ID: 22431675
[TBL] [Abstract][Full Text] [Related]
16. Rate of low vitamin D levels in a low-risk obstetric population.
Kaloczi LD; Deneris A
J Midwifery Womens Health; 2014; 59(4):405-10. PubMed ID: 24930428
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence.
Boltjes R; Knippenberg S; Gerlach O; Hupperts R; Damoiseaux J
Expert Rev Neurother; 2021 Jun; 21(6):715-725. PubMed ID: 34058936
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis.
Soilu-Hänninen M; Laaksonen M; Laitinen I; Erälinna JP; Lilius EM; Mononen I
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):152-7. PubMed ID: 17578859
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats.
Feige J; Moser T; Bieler L; Schwenker K; Hauer L; Sellner J
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32188044
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.
Munger KL; Åivo J; Hongell K; Soilu-Hänninen M; Surcel HM; Ascherio A
JAMA Neurol; 2016 May; 73(5):515-9. PubMed ID: 26953778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
